The UAB NF Program is internationally recognized for its contributions to outstanding clinical care, research, and education related to all forms of neurofibromatosis (NF1, NF2, and schwannomatosis). We are the national coordinating center for the NF Clinical Trials Consortium, funded by the Department of Defense to perform clinical trials for all forms of neurofibromatsis.
The last hope: UAB’s Undiagnosed Diseases ProgramFor a medical mystery that defies explanation or diagnosis, the Undiagnosed Diseases Program at the University of Alabama at Birmingham is the court of last resort. Launched in October 2013, the program aims to unravel the most perplexing medical cases in which a diagnosis has not previously been made.
Clinical Services: Our goal is to deliver outstanding care for patients and families through integrated clinical and laboratory services. For some conditions, we are considered a national and international referral source.
Research: We seek to expand knowledge and create new applications through laboratory and clinical research along the continuum from fundamental studies to preclinical investigations, to bench-to bedside translation, to clinical practice and community implementation.